Blizou, M.; Lampadakis, S.; Karofylakis, E.; Blizou, A.; Thomas, K.; Prountzos, S.; Papavasileiou, V.; Raptakis, T.; Manali, E.D.; Papiris, S.A.;
et al. Combination Treatment of Persistent SARS-CoV-2 Infection with Dual Antiviral Therapy and Intravenous Immunoglobulin: A Novel Approach. J. Clin. Med. 2025, 14, 8831.
https://doi.org/10.3390/jcm14248831
AMA Style
Blizou M, Lampadakis S, Karofylakis E, Blizou A, Thomas K, Prountzos S, Papavasileiou V, Raptakis T, Manali ED, Papiris SA,
et al. Combination Treatment of Persistent SARS-CoV-2 Infection with Dual Antiviral Therapy and Intravenous Immunoglobulin: A Novel Approach. Journal of Clinical Medicine. 2025; 14(24):8831.
https://doi.org/10.3390/jcm14248831
Chicago/Turabian Style
Blizou, Myrto, Stefanos Lampadakis, Emmanouil Karofylakis, Andromachi Blizou, Konstantinos Thomas, Spyridon Prountzos, Vasileios Papavasileiou, Thomas Raptakis, Effrosyni D. Manali, Spyros A. Papiris,
and et al. 2025. "Combination Treatment of Persistent SARS-CoV-2 Infection with Dual Antiviral Therapy and Intravenous Immunoglobulin: A Novel Approach" Journal of Clinical Medicine 14, no. 24: 8831.
https://doi.org/10.3390/jcm14248831
APA Style
Blizou, M., Lampadakis, S., Karofylakis, E., Blizou, A., Thomas, K., Prountzos, S., Papavasileiou, V., Raptakis, T., Manali, E. D., Papiris, S. A., Loukides, S., & Antonogiannaki, E.-M.
(2025). Combination Treatment of Persistent SARS-CoV-2 Infection with Dual Antiviral Therapy and Intravenous Immunoglobulin: A Novel Approach. Journal of Clinical Medicine, 14(24), 8831.
https://doi.org/10.3390/jcm14248831
